SuchaNandMD

PubMed

• Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.
  Megan Othus, Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Mia Sydenham, Robert K Hills, Alan K Burnett, Sucha Nand, Sarit Assouline, Laura C Michaelis, Harry P Erb...> ;Leukemia & Lymphoma. 2023 Jan 1
• COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population.
  Stephanie Berg, Seo-Hyun Kim, Amy Wozniak, Oluwatobi Odetola, Saad Arain, Ahmed Aleem, James Coggan, Ami Dave, Elizabeth Elliott, Ryan Guerrettaz, Hina Dalal, Raymond ...> ;American Journal of Hematology. 2022 Jun 1
• 7 citations
  Hypercoagulability of COVID-19 and Neurological Complications: A Review.
  Patrick Moore, Fatema Esmail, Shuai Qin, Sucha Nand, Stephanie Berg> ;Journal of Stroke and Cerebrovascular Diseases. 2022 Jan 1
• Hypercellular bone marrow in aplastic anemia: A case report of two patients.
  Ryan Sweeney, Fatema Esmail, Kamran M. Mirza, Sucha Nand> ;Clinical Case Reports. 2021 Nov 1
• 7 citations
  Kidney Transplantation for Erdheim-Chester Disease.
  Jongwon Yoo, Cynthia Gunsteen, Sima Patel, Ted Clevy-Schneller, Sucha Nand, Divya Jain, Raquel Garcia-Roca, Amishi Desai, Sanjeev Akkina> ;Case Reports in Transplantation. 2020 Jul 13
• Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation.
  Christopher Felicelli, Nicolas Lopez-Hisijos, Reeba Omman, Daniel Shepherd, Vijayalakshmi Ananthanarayanan, Ameet R. Kini, Rhett P. Ketterling, Joseph J. Maleszewski, ...> ;The Journal of Heart and Lung Transplantation. 2020 Jul 7
• 8 citations
  Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia.
  Eunice S. Wang, Richard Aplenc, Deborah Chirnomas, Michael John Dugan, Salman Fazal, Swaminathan P. Iyer, Tara L. Lin, Sucha Nand, Kristen J. Pierce, Paul J. Shami, Je...> ;Leukemia & Lymphoma. 2020 May 20
• 10 citations
  Hemophagocytic Lymphohistiocytosis in Adults: Associated Diagnoses and Outcomes, a Ten-Year Experience at a Single Institution
  Stephen Jumic, Sucha Nand> ;Journal of Hematology. 2019 Dec 25
• 8 citations
  Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG...
  Megan Othus, Mikkael A. Sekeres, Sucha Nand, Guillermo Garcia-Manero, Frederick R. Appelbaum, Harry P. Erba, Eli Estey> ;Leukemia. 2019 Feb 1
• 6 citations
  Genetics of Hypercoagulable and Hypocoagulable States.
  Daulath Singh, Arjun Natarajan, Sucha Nand, Hanh P. Mai> ;Neurosurgery Clinics of North America. 2018 Oct 1
• 17 citations
  Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.
  Abby Statler, Megan Othus, Harry P. Erba, Thomas R. Chauncey, Jerald P. Radich, Steven Coutre, Anjali S. Advani, Sucha Nand, Farhad Ravandi, Sudipto Mukherjee, Mikkael...> ;Blood. 2018 Jun 21
• Myeloproliferative Neoplasms.
  Nand, S.> ;The New England journal of medicine. 2017 Aug 31
• 7 citations
  Neurological Complications of the Leukemias Across the Ages.
  Stephanie Berg, Sucha Nand> ;Current Neurology and Neuroscience Reports. 2017 Feb 22
• 25 citations
  Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling
  Jing Li, Andrew Volk, Jun Zhang, Joseph Cannova, Shaojun Dai, Caiqin Hao, Chenglong Hu, Jiewen Sun, Yan Xu, Wei Wei, Peter Breslin, Sucha Nand, Jianjun Chen, Ameet R. ...> ;Oncotarget. 2017 Jan 31
• 16 citations
  Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI.
  Megan Othus, Wim H. van der Putten, Bob Löwenberg, Stephen H. Petersdorf, Sucha Nand, Harry P. Erba, Frederick R. Appelbaum, Robert Kerrin Hills, Nigel H. Russell, Ala...> ;Haematologica. 2016 Jul 1
• γ-δ T-Cell Lymphoma With Disseminated Intravascular Coagulation and Autoimmune Hemolytic Anemia.
  Sammar Alsunaid, Shikha Jain, Sucha Nand> ;Federal Practitioner. 2016 May 1
• 9 citations
  Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients
  Nicholas J. Achille, Megan Othus, Kathleen Wren Phelan, Shubin Zhang, Kathrine A. Cooper, John E. Godwin, Frederick R. Appelbaum, Jerald P. Radich, Harry P. Erba, Such...> ;Leukemia Research. 2016 Mar 1
• 42 citations
  FAK Mediates a Compensatory Survival Signal Parallel to PI3K-AKT in PTEN-Null T-ALL Cells
  Dewen You, Junping Xin, Andrew Volk, Wei Wei, Rachel Schmidt, Gina Scurti, Sucha Nand, Eun-Kyoung Breuer, Paul C. Kuo, Peter Breslin, Ameet R. Kini, Michael I. Nishimu...> ;Cell Reports. 2015 Mar 31
• 6 citations
  Anaplastic large cell lymphoma involving the urinary bladder: A case report and review of the literature
  Haiyan Chen, Yanxia Li, Sucha Nand, Marcus L. Quek, Ameet R. Kini, Güliz A. Barkan> ;Diagnostic Cytopathology. 2015 Jan 1
• 77 citations
  Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
  Andrew Volk, Jing Li, Junping Xin, Dewen You, Jun Zhang, Xinli Liu, Yechen Xiao, Peter Breslin, Zejuan Li, Wei Wei, Rachel Schmidt, Xingyu Li, Zhou Zhang, Paul C. Kuo,...> ;The Journal of Experimental Medicine. 2014 Jun 2
• Heckathorn disease revisited
  Sucha Nand, Kevin Barton, Richard Schultz, Mary Klein, Ameet R. Kini> ;Blood. 2014 Feb 27
• 5 citations
  Commonly used drugs in hematologic disorders.
  Elise Anderes, Sucha Nand> ;Handbook of Clinical Neurology. 2014 Jan 1
• 2 citations
  Anemias excluding cobalamin and folate deficiencies.
  Stephanie Dublis, Shefali Shah, Sucha Nand, Elise Anderes> ;Handbook of Clinical Neurology. 2014 Jan 1
• 25 citations
  Intravascular Large B-Cell Lymphoma: A Difficult Diagnostic Challenge.
  Maria S. Khan, Mark McCubbin, Sucha Nand> ;Journal of Investigative Medicine High Impact Case Reports. 2014 Jan 1
• 59 citations
  A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
  Sucha Nand, Megan Othus, John E. Godwin, Cheryl L. Willman, Thomas H. Norwood, Dianna S. Howard, Steven Coutre, Harry P. Erba, Frederick R. Appelbaum> ;Blood. 2013 Nov 14
• Join now to see all

Journal Articles

• Relative Survival Following Response to 7 + 3 Versus Azacytidine Is Similar in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes: An Analysis of Four SWOG...  
  Sucha Nand, Mikkael A Sekeres, Nature
• Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients  
  Achille NJ, Othus M, Phelan K, Zhang S, Cooper K, Godwin J, Appelbaum FR, Radich J, Erba HP, Nand S, Zeleznik-Le N, Leuk Res, 1/1/2016
• Relation between event-free survival and overall survival in acute myeloid leukemia: A report from SWOG, HOVN/SAKK and MRC/NCRI  
  Othus M, van Putten W, Lowenberg B, Petersdorf SH, Nand S, Erba H, Appelbaum F, Hills R, Russell N, Burnett A, Estey E, Haematologica, 1/1/2016
• Heckathorn’s Disease Revisited  
  Nand S, Barton K, Schultz R, Klein M, Kini A, Blood, 1/1/2014
• Intravascular diffuse large B cell lymphoma A difficult diagnostic challenge  
  Khan M, McCubbin M, Nand S, J Investigative Medicine, 1/1/2014
• Anaplastic large cell lymphoma involving the urinary bladder A case report and review of literature  
  Chen H, Li Y, Nand S, Quek M, Kini A, Barkan G, Diagnostic Cytopathology, 1/1/2014
• Cerebral vein and sinus thrombosis: Risk factors, prognosis and treatment A modern approach  
  Paner A, Jay W, Nand S, Michaelis L, Neuro-ophthalmology, 1/1/2009
• Hypercoagulable states and the Eye  
  Czerlanis C, Jay W, Nand, S, Seminars in Ophthalmology, 1/1/2008
• Single agent lenalidomide induces a response in refractory T-cell post transplant lymphoproliferative disorder  
  Portell C, Nand S, Blood, 1/1/2008
• Hydroxyurea, azacytidine and gemtuzumab ozogamicin therapy in previously untreated patients with non-M3 acute myeloid leukemia and high-risk myelodysplastic syndrome i...  
  Nand S, Godwin J, Smith S, Barton K, Michaelis L, Alkan S, Veerappan R, Rychlik K, Germano E, Stiff P, Leukemia and Lymphoma, 1/1/2008
• Commentary: Blast Crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge  
  Nand S, Barton K, Leukemia and Lymphoma, 1/1/2007
• A unique case of acute promyelocytic leukemia showing monocytic differentiation after all trans-retinoic acid (ATRA) therapy  
  Naeem M, Harrison K, Barton K, Nand S, Alkan S, Eur J Haematol, 1/1/2006
• Thromboembolism in Cancer Patients: Pathogenesis and Treatment  
  Adess M, Eisner R, Nand S, Godwin J, Messmore H, Wehrmacher W, Clinical and Applied Thrombosis/Hemostasis, 1/1/2006
• Survival role of Protein Kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition  
  Alkan S, Huang Q, Ergin M, Denning MF, Nand S, Maududi T, Paner GP, Izban KF, Am J Hematol, 1/1/2005
• Proton Pump Inhibitors and Iron Deficiency: Is the Connection Real?  
  Nand S, Tanvetyanon T, Southern Medical Journal, 1/1/2004
• Herpes zoster during treatment with arsenic trioxide  
  Tanvetyanon T, Nand S, Ann Hematol, 1/1/2004
• Lymphoproliferative disorders in chronic hepatitis C infection  
  Idilman R, Colantoni A, DeMaria N, Alkan S, Nand S, van Thiel DH, J Viral Hepatitis, 1/1/2004
• Overexpression of the NOTCH ligand JAG2 in Malignant Plasma Cells from Multiple Myeloma Patients and Cell Lines  
  Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J, Nand S, Toor A, Alkan S, Smadja NV, Avet-Loiseau H, Lima C, Miele L, Coignet LJ, Blood, 1/1/2004
• Pancytopenia in hereditary hemorrhagic telangiectasia  
  Tanvetyanon T, Nand S, Br J Haematol, 1/1/2004
• Hairy cell leukemia developing in a background of polycythemia vera  
  Kelly NP, Alkan S, Nand, S, Arch Pathol Lab Med, 1/1/2003
• Overcoming recurrent cutaneous reactions from imatinib using once weekly dosing  
  Tanvetyanon T, Nand S, Annals of Pharmacotherapy, 1/1/2003
• A Phase III Comparison of High Dose Ara-C (HDARC) vs HDARC plus mitoxantrone in the treatment of First-relapsed or Refractory Acute myeloid leukemia A Southwest Oncolo...  
  Karanes C, Kopecky KJ, Grever MR, Hynes HE, Kraut EH, Vial RH, Lichtin A, Nand S, Samlowski WE, Appelbaum F, Leuk Res, 1/1/1999
• Heparin-Induced Thrombocytopenia and Thrombosis  
  Sun W, Nand S, Resident and Staff Physician, 1/1/1999
• A Phase II Trial of Interleukin-2 in Myelodysplastic Syndromes  
  Nand S, Stock W, Stiff P, Sosman J, Martone B, Radvany R, Br J Haematol, 1/1/1998
• MR of Leptomeningeal, spinal and posterior fossa amyloid  
  Horowitz S, Thomas C, Gruener G, Nand S, Shea J, Am J Neuroradiology, 1/1/1998
• Join now to see all

Books/Book Chapters

• Current Neurology and Neuroscience Reports 
  Chapter: Neurological Complications of Leukemias Across the Ages 
  Berg, S, Nand SEditors: Jose Biller.Springer2016
• Anticoagulation for the Neurosurgeon and Hemostasis in Neurosurgery 
  Chapter: Congenital Coagulation Disorders 
  Sterrenberg D, Nand SEditors: Christopher M Loftus.Springer2015
• Anticoagulation for the Neurosurgeon and Hemostasis in Neurosurgery 
  Chapter: Acquired Coagulation Disorders 
  Kruczek K, Cooper K, Mai H, Nand SEditors: Christopher Loftus.Springer2015
• The Handbook of Clinical Neurology-Neurological Aspects of Systemic Disease 
  Chapter: Anemias excluding Cobalamin and Folate Deficincy 
  Dublis, S, Shah S, Nand, S, Anderes EEditors: Jose Biller and Jose Ferro.2010
• The Handbook of Clinical Neurology-Neurological Aspects of Systemic Disease 
  Chapter: Commonly Used Drugs in Hematologic Disorders 
  Anderes E, Nand SEditors: Jose Biller and Jose Ferro.2010
• Neurology of Internal Medicine 
  Chapter: Disorders of Platelets 
  Stillwill JF, Pandya M, Nand S, Michaelis LEditors: Jose Biller, MD.Lippincott Williams and Wilkins, Philadelphia2007
• Neurology of Internal Medicine 
  Chapter: Thrombotic Disorders 
  Broderick W, Nand S, Michaelis LEditors: Jose Biller, MD.Lippincott Williams and Wilkins, Philadelphia2007
• Myelodysplastic Syndromes. Approach to Diagnosis and Treatment 
  Schumacher, H., Nand, S.Williams and Wilkins (Igaku Shoin), Baltimore1995
• Join now to see all

Abstracts/Posters

• Germline Mutations Predispose to Familial Myeloproliferative Neoplasms
  Sucha Nand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Increased risk of sternal complications in patients with plasma cell dyscrasias undergoing coronary artery bypass graft
  Bufalino S, Patel M, Kothari A, Kuo P, Nand S, Blood, Lymphoma and Myeloma, New York, 1/1/2016
• Complete Remissions (CRs) with azacitidine regimens compared to CRs with 7+3 induction chemotherapy and the effect on overall survival
  Othus M, Sekeres MA, Nand, S, Garcia-Manero G, Appelbaum FR, Erba HP, Estey Ethus M, Sekeres MA, Nand, S, Garcia-Manero G, Appelbaum FR, Erba HP, Estey E, ASH, 1/1/2016
• Outcome of patients eligible and ineligible for leukemia studies conducted through SWOG
  Statler A, Othus M, Erba H, Chauncey T, Radich J, Coutre S, Advani A, Nand, S, Ravandi F, Mukherjee S, Sekeres M, ASH, 1/1/2016
• Association between early promoter-specific DNA methylation changes and outcome in older acute leukemia patients treated on SWOG S0703 (NCT00658814)
  Nand S, Achille N, Othus M, Phelan K, Zhang S, Cooper K, Godwin J, Appelbaum F, Radich J, Erba H, Zeleznik-Le N, ASCO, 1/1/2015
• Prevalence of Multiple Primary Hematologic Malignancies Seen at a Tertiary Care Center
  Cooper K, Lattell J, Gonzalez B, Kleithermes S, Nand S, Blood, 1/1/2015
• Sensitizing acute myeloid leukemia cells to interferon-induced differentiation by inhibiting RIP1/RIP3 pathway
  Xin J, You D, Volk A, Zhang J, Li J, Schmidt R, Ni A, Ng G, Wei W, Xia Z, Xiao Y, Gutierrez R, Pan J, Breslin P, Chen H, Kuo P, Nand S, Zhang J, Chen J. Zhang J, ASH, 1/1/2014
• Germ-line and somatic mutations in familial myeloproliferative neoplasms (MPNs). A pilot study
  Nand S, Diaz M, Marinier D, Walshauser M, Rosenfeld A, Michaelis L, Stiff P, Gai X, ASH, 1/1/2014
• A Phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC-720568) as induction and post-remission therapy in patients of age 60 and older with previo...
  Nand S, Gundacker H, Godwin J, Willman C, Norwood T, Erba H, Howard D, Coutre S, Othus M, Appelbaum F, J Clin Oncol, 1/1/2012
• Sensitizing leukemic cells to NFk-B inhibitor treatment by repressing TNF-alpha-mediated, NFk-B independent survival signaling
  Volk A, Xiao Y, Xin J, You D, Schmidt R, Zhang S, Wei W, Breslin P, Nand S, Zhang J, ASH, 1/1/2012
• A Phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC-720568) as induction and post-remission therapy in patients of age 60 or older with previou...
  Nand S, Othus M, Godwin J, Willman C, Norwood T, Erba HP, Howard D, Coutre S, Appelbaum F, ASH, 1/1/2012
• Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed acute promyelocytic leukemia
  Shepard DD, Kohrt HE, Rosenblat TL, Jurcic JG, Park JH, Goldman A, Dalal JS, Maslak PG, Jakubowski AA, Klimek V, Berman E, Nand S, Coutre SE, Tallman MS, Erba HP, J Clin Oncol, 1/1/2011
• Limitations of performance status (PS) assignment in predicting outcomes of acute myeloid leukemia (AML) and the role of objective parameters in predicting PS assignment
  Phelan KW, Nand S, Michaelis L, Blood, 1/1/2011
• Promoter methylation of selected genes and response to azacitidine (AZ) therapy in patients with non BCR-ABL myeloproliferative disorders (MPDs)
  Achille N, Michaelis L, Smith SE, Germano E, Zeleznik-Le N, Nand S, Blood, 1/1/2011
• Azacitidine and low dose gemtuzumab ozogamicin for treatment of poor-risk acute myeloid leukemia and myelodysplastic syndromes including relapsed/refractory disease
  Michaelis L, Shafer D, Stiff P, Nand S, ASH, 1/1/2009
• Treatment of acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly with azacitidine and gemtuzumab ozogamicin
  Nand S, 9th International Symposium on Myelodysplastic syndromes, Florence, Italy, 1/1/2007
• Treatment of acute myeloid leukemia and high risk myelodysplastic syndrome in the elderly with azacitidine and gemtuzumab ozogamicin
  Nand S, Godwin J, Smith S, Barton K, Germano E, Stiff P, Leukemia Research, 1/1/2007
• Azacitidine plus gemtuzumab (GO): a novel combination in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) in the elderly
  Nand S, Godwin J, Smith S, Barton K, Germano E, Stiff P, Blood, 1/1/2006
• Allogeneic transplantation for acute myeloid leukemia M2 with 8;21 translocation and CD56 positivity is effective for relapsed disease
  Tanvetyanon T, Nand S, Toor A, Rodriguez T, Parthasarthy M, Stiff P, Blood, 1/1/2004
• A phase I/II study of induction therapy with topotecan, mitoxantrone and etoposide in Relapsed/Refractory AML, Myelodysplasia and Myeloid Blast Crisis
  Nand S., Godwin J., White C., Beltran O., Stiff P., Blood, 1/1/2000
• A Phase I/II study of topotecan, mitoxantrone and etoposide n refractory/relapsed AML, myeloid blast crisis and high risk myelodysplastic syndromes
  Nand S., Stiff P., Beltran O., Godwin J., Blood, 1/1/1999
• Protein Kinase C in chronic lymphocytic leukemia. Patterns of Isoform expression and Role in apoptosis
  Pooley R., Ergin M., Denning M.F., Amin H., Nand S., Alkan S., U.S. and Candian Acad of Path, 1/1/1999
• Home treatment of uncomplicated sickle cell crissis
  Nand S., Zakrzewski S., Vercruysse R., Beleg M., Kareb J., Fisher S.G., Blood, 1/1/1998
• Heparin-induced thrombocytopenia with thrombosis. Risk factors and clinical outcomes in 108 consecutive patients treated at a single institution
  Nand S, Thromb and Haemosta, Florence, Italy, 1/1/1997
• A Phase II Study of Interleukin-2 in Myelodysplastic Syndromes
  Nand S., Stock W., Stiff P., Sosman J., Martone B., Radvany R., Blood, 1/1/1997
• Join now to see all

Lectures

• Cancer-Associated Thromboembolism 
  Loyola University Medical Center - 1/1/2004
• Management of Anemia of Cancer 
  Joliet - 1/1/2002
• Radioimmunotherapy of non-Hodgkin’s Lymphoma 
  Good Samaritan Hospital, Downers Grove, IL - 1/1/2002
• Treatment of Myelodysplastic Syndrome Lessons from the Adult Population 
  Moscow - 1/9./1994
• Acute Leukemia in Hydroxyurea Treated Polycythemia Vera 
  Bethesda, MD - 1/8./1995
• Therapeutic Apheresis in Malignancy 
  Kyoto, Japan - 1/4./1996
• Heparin-induced Thrombocytopenia with Thrombosis 
  University of Illinois Hospital, Chicago, 1997; St. John’s Mercy Medical Center (University of Misso - 1/11/1999
• Benign and Malignant Lymphoproliferative disorders associated with Hepatitis C infection 
  Loyola University Medical Center - 1/11/1999
• Acute Myeloid Leukemia, an Update 
  Cook County Hospital, Chicago - 1/16/2000
• Lymphoproliferative disease and HCV infection 
  Loyola University - 1/16/2000
• Myelodysplastic syndromes 
  University of Illinois Medical Center, 2001; St. John’s Mercy Medical Center (University of Missouri - 1/21/2002
• Management of Cancer-Related Anemia 
  Ingalls Memorial Hospital, Harvey, IL - 1/19/2003
• Hypercoagulable States and Cardiovascular System 
  Division of Cardiology, Loyola University Medical Center - 1/10/2003
• Radio-immunotherapy of Follicular Non-Hodgkin’s Lymphoma 
  Thomas Jefferson University Medical Center, Philadelphia, PA - 1/1./2003
• Radio-immunotherapy. A new therapeutic option for patients with Follicular Non-Hodgkin’s lymphoma 
  Hahneman University Medical center, Philadelphia, PA - 1/1./2003
• New choices in the treatment of Follicular Non-Hodgkin’s Lymphoma 
  Memorial Hospital/Southern Illinois University, Springfield, IL - 1/29/2004
• Anemia in pre-dialysis chronic kidney disease 
  Loyola University Medical Center - 1/8./2004
• Chronic Myeloproliferative Disorders 
  Sherman Hospital, Elgin - 1/14/2004
• Perioperative thrombosis and its management 
  Loyola University Medical Center - 1/24/2004
• Myelodysplastic syndromes. Past, Present and Future 
  Mt Sinai Hospital, Chicago - 1/14/2005
• Multiple Myeloma. An Update 
  University of South Dakota, Sioux Falls - 1/13/2005
• Diagnosis of and Approach to Anemias 
  Advocate Lutheran General Hospital, Park Ridge, Illinois - 1/7./2009
• Join now to see all

Other

• Polycythemia and its neurologic complications 
  Nand S, Kostidis, A, Sarkis Morales-Vidal, MedLink (Online publication)
  1/1/2011